Pharmascience in Brief

About Us

Founded in 1983, Pharmascience is a leading manufacturer of generic drugs in a wide range of therapeutic categories.

We are a privately owned company with technologically sophisticated operations designed to satisfy customer expectations for quality products and responsive service.

Pharmascience's annual sales exceed CAD$700 million and we employ more than 1,300 highly-qualified people. Our state-of-the-art R&D laboratory and production facilities are located in Montreal, Quebec. Our Canada-wide customer base includes pharmacists, drug wholesalers and major retailers.

Investment in research and development at Pharmascience amounts to CAD$30 million annually. In 2011, we invested CAD$40 million to expand our facilities.

Pharmascience is distinguished by an enriched customer experience adapted to your needs and a portfolio of high quality medicines trusted by patients worldwide.

Pharmascience Quick Facts

  •   1.
    Co-founded by pharmacists Morris Goodman and Ted Wise in 1983;
  •   2.
    Largest pharmaceutical employer in Quebec, Canada, with 1,300 employees;
  •   3.
    Third largest generic pharmaceutical company in Canada and third largest pharmaceutical company in Canada by number of prescriptions;
  •   4.
    Ranked 52nd among Canada's top 100 R&D investors with CAD$30 million invested annually;
  •   5.
    Diversified portfolio of over 340 product families, both prescription and over-the-counter;
  •   6.
    Sales in more than 60 countries with annual sales topping CAD$700 million;
  •   7.
    One of the largest providers of generic single-source products;
  •   8.
    A leader in customer service & support.

Morris Goodman

Chairman of the Board

As one of Canada's leading entrepreneurs and a pioneer in the generic drug industry, Mr. Goodman has dedicated his career to Creating the Difference in healthcare in Canada and worldwide. He graduated from the Faculty of Pharmacy at the University of Montreal in 1953 at the young age of twenty-one.

After graduation, Mr. Goodman focused on the industry side of pharmacy and quickly obtained distribution rights from several international pharmaceutical companies to bring their products to the Canadian marketplace. He marketed and sold these products in Canada under the company name of Winley-Morris Co. Ltd.

In 1971, Mr. Goodman approached a California-based company, International Chemical & Nuclear Corporation (ICN) and became their Canadian distributor of L-Dopa. Impressed with his innovative approach, they purchased Winley-Morris and established Morris Goodman as President of ICN Canada.

In 1983, Mr. Goodman co-founded Pharmascience Inc. with his good friend and colleague, Ted Wise. As Co-Founder & Chairman of the Board of Pharmascience Inc., Morris Goodman has been at the forefront of the company's explosive growth and development, leading it to its current standing as one of the top three generic pharmaceutical companies in Canada.

Notwithstanding his business successes, Mr. Goodman is a leader in philanthropic initiatives.  Included among the major charitable donations made by The Morris & Rosalind Goodman Family Foundation are The Stroke Unit at the Jewish General Hospital, the Agora at the Faculty of Pharmacy at the University of Montreal and The Rosalind and Morris Goodman Cancer Research Centre at McGill University.

In May of 2011, McGill University bestowed an honorary degree upon Mr. Goodman.

David Goodman

Chief Executive Officer

Dr. David Goodman is Chief Executive Officer of Pharmascience, which is today the 2nd largest privately-owned pharmaceutical company in Canada.

Dr. Goodman obtained his Bachelor degree in Commerce from McGill University, and his Ph.D. in pharmacology from the University of Virginia. Upon graduation, he began his career at Pharmascience in Business Development and has gained significant experience in progressively senior international and domestic roles.

Under Dr. Goodman's leadership, Pharmascience has gone from being a strictly Canadian company to becoming an important player on the global stage. Pharmascience strives to be the first company to launch its generic pipeline in Canada, Europe and various markets throughout the world.

Dr. Goodman's success is his belief and insistence on major and constant investment in internal and external R&D programs, as well as in employee development.

Larry MacGirr

Chief Operations Officer

As Chief Operating Officer, Larry brings a dynamic, personable leadership style to Pharmascience Inc. Larry is responsible for the strategic oversight of Pharmascience, inspiring out of the box thinking throughout the company.

During his 17 years at Ciba Vision Corp., Larry rose to Vice President Sales-North American Lens Business before being promoted to General Manager-Canada. Throughout his career, Larry has been a keen advocate of fostering strong relationships, connecting with clients and business partners alike, generating profound insights that benefit their business in unexpected ways.

Larry holds a Bachelor degree in Business Administration form York University, and has also participated in executive-focused programs at Harvard and Cornell. He is continually seeking new ideas that will bring unique value to our customers and ensure Pharmascience’s continued success.